Europe’s medicines regulator said on March 4 that the EMA started a rolling review of Russia’s Sputnik V Covid-19 vaccine, an important display of confidence in the shot that paves the way for its potential approval across the 27-nation bloc.
If you are not happy with the results below please do another search
50 search results for:
Teva is being investigated by EU antitrust regulators who are looking into whether the company illegally hindered rivals’ access to the Israeli drugmaker’s multiple sclerosis medicine Copaxone.
Recent data on Covid-19 vaccinations with the Pfizer/BioNTech and AstraZeneca shots are encouraging, the European regional adviser to the World Health Organization told reporters on March 3.
U.S. President Joe Biden met with a bipartisan group of lawmakers at the White House on March 3 to brainstorm ways to accelerate the fight against cancer, saying he believed the world was nearing some “real breakthroughs.”
The White House said on March 3 that President Joe Biden hoped Americans would continue to follow coronavirus guidelines such as mask-wearing even as some states, including Texas, lift their restrictions amid the ongoing pandemic.
Caribou Biosciences secured $115 million in an oversubscribed Series C financing round that will be used to advance the company’s pipeline of wholly owned allogeneic immune cell therapies for oncology and its next-generation CRISPR technology platform.
Shares of Ovid Therapeutics soared in trading after the company announced pharma giant Takeda signed a licensing agreement valued at $856 million to secure global rights to the investigational medicine soticlestat for the treatment of two forms of rare epilepsy.
Vir Biotechnology and Britain’s GlaxoSmithKline said on March 3 they would pause enrollment into a study testing their experimental Covid-19 antibody therapy, which is a part of a large U.S. trial.
The gout medication colchicine will be tested in a large UK study looking into potential early-stage Covid-19 treatments and enrollment criteria was widened for the latest arm of the trial, University of Oxford researchers said on March 3.
Texas Governor Greg Abbott issued the most sweeping rollback of coronavirus restrictions of any U.S. state on March 2, lifting a mask mandate and saying most businesses may open at full capacity by the following week.